A detailed history of New Republic Capital, LLC transactions in Pfizer Inc stock. As of the latest transaction made, New Republic Capital, LLC holds 8,102 shares of PFE stock, worth $203,603. This represents 0.13% of its overall portfolio holdings.

Number of Shares
8,102
Previous 10,030 19.22%
Holding current value
$203,603
Previous $281 Million 16.45%
% of portfolio
0.13%
Previous 0.14%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 04, 2024

SELL
$27.7 - $31.39 $53,405 - $60,519
-1,928 Reduced 19.22%
8,102 $234 Million
Q2 2024

Aug 14, 2024

BUY
$25.26 - $29.6 $253,357 - $296,888
10,030 New
10,030 $281 Million
Q2 2023

Aug 14, 2023

BUY
$36.12 - $41.79 $279,893 - $323,830
7,749 New
7,749 $284 Million
Q1 2023

Sep 12, 2023

SELL
$39.39 - $51.28 $65,111 - $84,765
-1,653 Reduced 21.33%
6,096 $249 Million
Q4 2022

Sep 12, 2023

SELL
$41.75 - $54.5 $47,595 - $62,130
-1,140 Reduced 14.71%
6,609 $339 Million

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $141B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track New Republic Capital, LLC Portfolio

Follow New Republic Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of New Republic Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on New Republic Capital, LLC with notifications on news.